Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 19, 1996

View Archived Issues

Therapeutically active nicotinic acid esters described by Scotia

Bayer describes new ASA derivatives

New lipophilic drug delivery agents from Scotia

Radiopharmaceutical agents from CIS Bio International

Mercian reports new antitumor anthracycline

Antineoplastic anthracycline antibiotic disclosed by Mercian

Innapharma reports novel antidepressant

DuPont Merck developing atypical antipsychotic

DuPont Merck reports ester prodrugs for glaucoma

NK1 receptor antagonist synthesized by RPR

5-LO inhibitor under evaluation at SKB

HemispheRx and Temple University enter new agreement for Oragen products

MedImmune receives patent coverage for RespiGam

Antex to be issued patent covering H. influenzae proteins

Prostate cancer gene therapy trial commences

The role of host factors in HIV pathogenesis

Innovative NRT recommended for approval

New insights into migraine pathology

Carrington Laboratories and Recordati reach licensing agreement

Positive phase II results with RMP-7/carboplatin

Clinical trial on OXiGENE's Sensamide/Neu-Sensamide nearing completion

Medtronic and Orphan Medical to develop intrathecal clonidine

Circularly permuted proteins and fusion proteins available for licensing

Licensees sought for vector for polynucleotide vaccines

Heterologous vectors for boosting antitumor immunity available for licensing

Licenses offered for marker in the human iNOS gene promoter region

Knoll licenses technology for use in cardiovascular research

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...